485 results match your criteria Pancreatic Serous Cystadenoma Imaging

Quantitative MRI of Pancreatic Cystic Lesions: A New Diagnostic Approach.

Healthcare (Basel) 2022 Jun 2;10(6). Epub 2022 Jun 2.

Department of Medical Imaging, "Iuliu Hațieganu" University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.

The commonly used magnetic resonance (MRI) criteria can be insufficient for discriminating mucinous from non-mucinous pancreatic cystic lesions (PCLs). The histological differences between PCLs' fluid composition may be reflected in MRI images, but cannot be assessed by visual evaluation alone. We investigate whether additional MRI quantitative parameters such as signal intensity measurements (SIMs) and radiomics texture analysis (TA) can aid the differentiation between mucinous and non-mucinous PCLs. Read More

View Article and Full-Text PDF

Cystic Lesions of the Pancreas: Is Apparent Diffusion Coefficient Value Useful at 3 T Magnetic Resonance Imaging?

J Comput Assist Tomogr 2022 May-Jun 01;46(3):363-370. Epub 2022 Apr 8.

From the Department of Diagnostic Imaging, Pisa University Hospital.

Objective: The objective of this study is to determine the role of apparent diffusion coefficient (ADC) value at 3T magnetic resonance imaging (MRI) in the characterization of pancreatic cystic lesions.

Methods: We retrospectively selected a total number of 223 patients with a conclusive diagnosis of pancreatic cystic lesion, previously undergoing MR examination on a 3 T system. The MRI protocol first included axial T1/T2-weighted sequences and magnetic resonance cholangiopancreatography. Read More

View Article and Full-Text PDF

Pancreatic serous cystadenoma with a positive octreotide scan.

Gastrointest Endosc 2022 Jun 2;95(6):1269-1270. Epub 2022 Feb 2.

Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article and Full-Text PDF


Arq Bras Cir Dig 2022 31;34(4):e1640. Epub 2022 Jan 31.

Centro de Gastroenterologia e Endoscopia Digestiva de Natal, Hospital Universitário Onofre Lopes da Universidade Federal do Rio Grande do Norte (HUOL - UFRN) - Natal, Rio Grande do Norte (RN), Brasil.

Aim: Many patients with serous cystadenoma of the pancreas (SCP) underwent surgery due to diagnostic doubt. The aim of this study was to analyze the causes of low accuracy in diagnosing SCP.

Methods: This is a retrospective study of patients with SCP from a database of two hepatopancreatic biliary surgery outpatient clinics between 2006 and 2020. Read More

View Article and Full-Text PDF
February 2022

Pancreatic serous cystadenocarcinoma diagnosed with liver metastasis at 7 years after the resection of the primary serous neoplastic lesion.

Clin J Gastroenterol 2022 Apr 11;15(2):505-512. Epub 2022 Jan 11.

Department of Pathology, International University of Health and Welfare, Mita Hospital, 1-4-3 Mita, Minato-ku, Tokyo, 108-8329, Japan.

Pancreatic serous neoplasms are rare tumors that are usually benign. However, histopathological differentiation between benign (serous cystadenoma) and malignant (serous cystadenocarcinoma) lesions is difficult. We present the case of a patient with pancreatic serous cystadenocarcinoma that was diagnosed with liver metastasis 7 years after the resection of the primary serous neoplastic lesion. Read More

View Article and Full-Text PDF

Pancreatic Serous Cystic Neoplasms and Mucinous Cystic Neoplasms: Differential Diagnosis by Combining Imaging Features and Enhanced CT Texture Analysis.

Front Oncol 2021 23;11:745001. Epub 2021 Dec 23.

Department of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Objective: To establish a diagnostic model by combining imaging features with enhanced CT texture analysis to differentiate pancreatic serous cystadenomas (SCNs) from pancreatic mucinous cystadenomas (MCNs).

Materials And Methods: Fifty-seven and 43 patients with pathology-confirmed SCNs and MCNs, respectively, from one center were analyzed and divided into a training cohort (n = 72) and an internal validation cohort (n = 28). An external validation cohort (n = 28) from another center was allocated. Read More

View Article and Full-Text PDF
December 2021

Pancreatic Lymphangioma: An Unusual Cause of Abdominal Lump.

Cureus 2021 Nov 10;13(11):e19452. Epub 2021 Nov 10.

General Surgery, All India Institute of Medical Sciences, Raipur, IND.

Lymphangiomas are uncommon benign malformations that can occur anywhere in the body. These are hamartomatous malformations with lymphatic differentiation, which uncommonly involve the abdomen and rarely the pancreas. The size of the cysts in pancreatic lymphangioma directly correlates with the clinical manifestations; however, most of them are non-specific. Read More

View Article and Full-Text PDF
November 2021

Non-inflammatory pancreatic cysts: from diagnosis to treatment (97 cases series).

Rev Col Bras Cir 2021 22;48:e20213009. Epub 2021 Nov 22.

- Universidade Federal do Rio Grande do Norte (UFRN), Unidade de Diagnóstico por Imagem e Métodos Gráficos do Hospital Universitário Onofre Lopes - Natal - RN - Brasil.

Objective: to describe the implications of the diagnosis and treatment of non-inflammatory pancreatic cysts in a series of patients.

Methods: we included patients with pancreatic cysts ≥1.0 cm, excluding those with a presumptive diagnosis of a pseudocyst. Read More

View Article and Full-Text PDF
November 2021

Ga-FAPI-46 PET/MR Detects Recurrent Cholangiocarcinoma and Intraductal Papillary Mucinous Neoplasm in a Patient Showing Increasing CEA with Negative F-FDG PET/CT and Conventional CT.

Nucl Med Mol Imaging 2021 Oct 23;55(5):257-260. Epub 2021 Aug 23.

National Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy, Kamphangpetch 6 Road, Laksi Bangkok, 10210 Thailand.

A patient with intrahepatic cholangiocarcinoma who underwent hepatic resection with completed neoadjuvant chemotherapy presented with increased CEA levels. Previous whole abdominal and chest CT scan revealed no evidence of local recurrence or metastasis.  Ga-FAPI-46 PET showed significantly higher tumor-to-background contrast of recurrent tumor and nodal metastasis, which were undetectable in the FDG PET or conventional CT scan. Read More

View Article and Full-Text PDF
October 2021

Updates in diagnosis and management of pancreatic cysts.

Linda S Lee

World J Gastroenterol 2021 Sep;27(34):5700-5714

Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, MA 02115, United States.

Incidental pancreatic cysts are commonly encountered with some cysts having malignant potential. The most common pancreatic cystic neoplasms include serous cystadenoma, mucinous cystic neoplasm and intraductal papillary mucinous neoplasm. Risk stratifying pancreatic cysts is important in deciding whether patients may benefit from endoscopic ultrasound (EUS) or surgical resection. Read More

View Article and Full-Text PDF
September 2021

Young Woman with Periumbilical Abdominal Pain.

Jun Huang Li Li

Ann Emerg Med 2021 09;78(3):e27-e28

Department of Pediatrics, Changzhou Fourth People's Hospital, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China.

View Article and Full-Text PDF
September 2021

Pancreatic Neuroendocrine Tumor with Benign Serous Cystadenoma: A Rare Entity.

Case Rep Oncol Med 2021 4;2021:9979998. Epub 2021 Aug 4.

Department of Gastrointestinal and General Surgery, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Mixed serous-neuroendocrine neoplasm constitutes pancreatic serous cystic neoplasms and pancreatic neuroendocrine tumor, two tumor components with different underlying pathologies. The differentiation of these tumors is important as the management and prognosis depend on the pancreatic neuroendocrine tumor component. We report a case of mixed serous-neuroendocrine neoplasm in a 47-year-old female who presented with epigastric pain abdomen for two years. Read More

View Article and Full-Text PDF

State-of-the-Art Update of Pancreatic Cysts.

Dig Dis Sci 2022 05 12;67(5):1573-1587. Epub 2021 Aug 12.

Division of Gastroenterology Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.

Andrew Canakis. Read More

View Article and Full-Text PDF

Cystic pancreatic lesions: MR imaging findings and management.

Insights Imaging 2021 Aug 10;12(1):115. Epub 2021 Aug 10.

Department of Radiology, Regional Hospital Ca' Foncello, Piazza Ospedale 1, 3100, Treviso, Italy.

Cystic pancreatic lesions (CPLs) are frequently casual findings in radiological examinations performed for other reasons in patients with unrelated symptoms. As they require different management according to their histological nature, differential diagnosis is essential. Radiologist plays a key role in the diagnosis and management of these lesions as imaging is able to correctly characterize most of them and thus address to a correct management. Read More

View Article and Full-Text PDF

MRI is useful to suggest and exclude malignancy in mucinous cystic neoplasms of the pancreas.

Eur Radiol 2022 Feb 10;32(2):1297-1307. Epub 2021 Aug 10.

Assistance Publique-Hôpitaux de Paris, APHP.Nord, Department of Radiology, Beaujon University Hospital, 100 bd general Leclerc, 92110, Clichy, France.

Objectives: To evaluate the value of MRI in differentiating benign (b-MCN) and malignant (m-MCN) MCN. European guidelines suggest that certain mucinous cystic neoplasms (MCN) of the pancreas can be conservatively managed.

Methods: A retrospective single-center study of consecutive patients with resected MCN. Read More

View Article and Full-Text PDF
February 2022

Evaluating the added benefit of CT texture analysis on conventional CT analysis to differentiate benign ovarian cysts.

Diagn Interv Radiol 2021 Jul;27(4):460-468

Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea.

Purpose: We aimed to evaluate the benefit of adding CT texture analysis on conventional CT features of benign adnexal cystic lesions, especially in identifying mucinous cystadenoma.

Methods: This retrospective study included patients who underwent surgical removal of benign ovarian cysts (44 mucinous cystadenomas, 32 serous cystadenomas, 16 follicular/simple cysts and 43 endometriotic cysts) at our institution between January 2015 and November 2017. The CT images were independently reviewed by an abdominal radiologist (reviewer 1) and a resident (reviewer 2). Read More

View Article and Full-Text PDF

Solid serous cystadenoma of the pancreas: A rare tumor with challenging differential diagnosis.

Hepatobiliary Pancreat Dis Int 2022 06 26;21(3):303-306. Epub 2021 Jun 26.

General and Oncologic Surgery Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Via Carlo Forlanini 34, 47121, Forlì, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article and Full-Text PDF

Benign macrocystic serous cystadenoma of the pancreas.

Indian J Pathol Microbiol 2021 Jun;64(Supplement):S166-S168

Department of Pathology, Bolu Abant Izzet Baysal University, Turkey.

Serous cystadenoma is a rare benign cystic lesion of pancreas. They are mostly known as benign cystic tumors of pancreas but malign transformation as serous cystadenocarcinoma is also reported. It is more commonly observed in women with the mean age of onset is 62 years. Read More

View Article and Full-Text PDF

Multiparameter Analysis Using F-FDG PET/CT in the Differential Diagnosis of Pancreatic Cystic Neoplasms.

Contrast Media Mol Imaging 2021 7;2021:6658644. Epub 2021 Apr 7.

Department of Nuclear Medicine, The First Medical Centre, Chinese PLA General Hospital, Fuxing Road 28, Beijing 100853, China.

Purpose: To evaluate multiparametric analysis in differential diagnosis between pancreatic serous cystic neoplasms (SCNs) and mucinous cystic neoplasms (MCNs) as well as the differentiation of the benign and malignant MCNs with F-FDG (18-fluorodeoxyglucose) PET/CT (positron emission tomography).

Methods: Forty patients with total of 41 lesions (SCNs: 27/41; MCNs: 14/41), who were preoperatively examined with F-FDG PET/CT, were retrospectively analyzed. Multiple quantitative parameters using conventional and texture features were included. Read More

View Article and Full-Text PDF
December 2021

Cytologic Assessment of Cystic/Intraductal Lesions of the Pancreatobiliary Tract.

Michelle D Reid

Arch Pathol Lab Med 2022 03;146(3):280-297

From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.

Context.—: Because of new and improved imaging techniques, cystic/intraductal pancreatobiliary tract lesions are increasingly being discovered, and brushings or endoscopic ultrasound/computed tomography/magnetic resonance imaging-guided fine-needle aspiration biopsies from these lesions have become an integral part of pathologists' daily practice. Because patient management has become increasingly conservative, accurate preoperative diagnosis is critical. Read More

View Article and Full-Text PDF

A Novel Treatment for Metastatic Serous Cystadenocarcinoma Using a Microwave Ablation: Case Report and Review of the Literature.

Pancreas 2021 03;50(3):434-440

From the Division of Surgical Oncology, Department of Surgery.

Abstract: The incidence of pancreatic cystic neoplasms has grown because of increased detection. Among these lesions, serous cystadenoma was traditionally thought to be universally benign and indolent. However, there is an exceedingly rare malignant variant of serous cystadenoma known as serous cystadenocarcinoma (SCAC) that can exhibit local invasion into adjacent structures, hepatic implants, and metastatic spread to the abdominal viscera. Read More

View Article and Full-Text PDF

Added value of [Ga]Ga-DOTA-TOC PET/CT for characterizing pancreatic neuroendocrine neoplasms: a comparison with contrast-enhanced CT and/or MRI in a large study cohort.

Eur Radiol 2021 Oct 31;31(10):7734-7745. Epub 2021 Mar 31.

Department of Radiology, Seoul National University Hospital, 101 Daehakro, Jongno-gu, Seoul, 110-744, Korea.

Objectives: To investigate an additional value of [Ga]Ga-DOTA-TOC PET/CT for characterizing suspected pancreatic neuroendocrine neoplasms (NENs) in a large study cohort.

Methods: This retrospective study included 167 patients who underwent [Ga]Ga-DOTA-TOC PET/CT for suspected pancreatic NENs detected by contrast-enhanced CT (n = 153) and/or MRI (n = 85). Two board-certified radiologists independently reviewed CT and/or MRI as well as [Ga]Ga-DOTA-TOC PET/CT and scored the probability of NEN on a 5-point scale. Read More

View Article and Full-Text PDF
October 2021

Triple threat: pancreatic cystic lesion presenting with spontaneous hemorrhage is found to harbor three distinct neoplasms.

World J Surg Oncol 2021 Jan 15;19(1):15. Epub 2021 Jan 15.

HPB Surgery and Surgical Oncology, Valley Medical Group, Luckow Plaza, One Valley Health Plaza, Paramus, NJ, 07652, USA.

Background: Pancreatic serous cystadenoma (SCA) is a benign, cystic lesion with an indolent growth pattern. Complications such as spontaneous hemorrhage or malignant transformation from SCA are extremely rare. Our case report describes an unusual presentation of a patient with a previously diagnosed SCA, made unique by the presence of three separate neoplasms in the final specimen. Read More

View Article and Full-Text PDF
January 2021

Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report.

BMC Surg 2020 Dec 14;20(1):331. Epub 2020 Dec 14.

Pancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS Rozzano, Via Alessandro Manzoni, 56, 20089, Rozzano, Milan, Italy.

Background: Serous cysto-adenoma (SCA) is a rare benign neoplasm of the pancreas. SCA can mimic other pancreatic lesions, such as neuroendocrine tumours. 68Gallium-DOTA-peptide Positron Emission Tomography (PET) is able to image in vivo the over-expression of the somatostatin receptors, playing an important role for the identification of neuroendocrine neoplasms. Read More

View Article and Full-Text PDF
December 2020

Differentiating benign from malignant pancreatic cysts on computed tomography.

Eur J Radiol Open 2020 1;7:100278. Epub 2020 Nov 1.

Second Affiliated Hospital, Department of Radiology, Sun Yat-sen University, Guangzhou 510000, China.

Purpose: It is important to identify features on computed tomography (CT) that can distinguish between benign and premalignant or malignant pancreatic cysts to avoid unnecessary surgeries. This study investigated the preoperative diagnostic evaluation of cystic pancreatic lesions to determine how advanced imaging and clinical factors should guide management.

Methods: In total, 53 patients with 27 benign and 26 premalignant or malignant cysts were enrolled. Read More

View Article and Full-Text PDF
November 2020

Role of volumetric multiparametric MRI in distinguishing between intraductal papillary mucinous neoplasms and serous cystadenoma.

Abdom Radiol (NY) 2021 04 9;46(4):1629-1639. Epub 2020 Oct 9.

Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, 600 N Wolfe St, Room 143, Baltimore, MD, 21287, USA.

Purpose: To evaluate the use of volumetric multiparametric MRI in differentiating pancreatic intraductal papillary mucinous neoplasms (IPMNs) from serous cystadenomas (SCAs) METHODS: Included patients (123 patients with pancreatic cystic neoplasms (PCNs) measuring ≥ 10 mm) were stratified into two groups based on cyst type. Axial cyst size, region of interest (ROI)-based apparent diffusion coefficient (ADC) and volumetric data, including cyst volume, volumetric apparent diffusion coefficient (vADC), and volumetric venous enhancement (vVE) were extracted and compared between the two groups. Univariate and multiple logistic regression was used to develop models for distinguishing between IPMNs and SCAs. Read More

View Article and Full-Text PDF

Incidentally detected microcystic serous cystadenoma of the pancreas with splenic invasion: a case report and literature review.

BJR Case Rep 2020 Sep 29;6(2):20190109. Epub 2020 Sep 29.

Department of Diagnostic Radiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Serous cystic neoplasms are relatively uncommon and rarely possess malignant potential. We report a rare case of pancreatic serous cystadenoma with splenic invasion in a female in her 60s. Dynamic contrast-enhanced CT revealed a 3 cm mass in the tail of the pancreas. Read More

View Article and Full-Text PDF
September 2020

Non-Neoplastic and Neoplastic Cysts of the Pancreas.

Monogr Clin Cytol 2020 28;26:53-73. Epub 2020 Sep 28.

Office of Chief Medical Examiner, New York, New York, USA.

Inflammatory, developmental, and neoplastic lesions may all present as cystic masses on imaging. Pseudocyst is the most common of these and presents in association with a history of pancreatitis. Pancreatic cystic neoplasms are uncommon compared to solid neoplasms. Read More

View Article and Full-Text PDF
October 2021

Laparoscopic Central Pancreatectomy with Pancreato-Gastric Anastomosis for Pancreatic Cystadenoma.

Chirurgia (Bucur) 2020 Jul-Aug;115(4):520-525

We present the case of a 42-year-old woman diagnosed with a cystic pancreatic lesion, suggestive of a serous cystadenoma of 27/13 mm. The diagnosis was established by the examination of abdominal CT and eco-endoscopy. The patient was referred to the surgery department for treatment. Read More

View Article and Full-Text PDF
October 2020

Pearls and pitfalls of imaging features of pancreatic cystic lesions: a case-based approach with imaging-pathologic correlation.

Jpn J Radiol 2021 Feb 25;39(2):118-142. Epub 2020 Aug 25.

Department of Radiology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

A variety of neoplastic and non-neoplastic lesions of the pancreas can present with a predominantly cystic architecture. These lesions are increasingly being detected as incidental findings on routine cross-sectional imaging following technological advances in these techniques and their widespread use. The different histopathological behaviors show various common and uncommon imaging findings, and some cases show similar appearance in spite of different histopathology. Read More

View Article and Full-Text PDF
February 2021